U
MJardin Group, Inc. MJARF
$0.00 $0.000.00% OTC PK
Recommendation
Dividend Power Score
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
EPS (TTM)

Company Overview

MJardin Group, Inc. was a North American cannabis management and cultivation company focused on the regulated cannabis industry in the United States and Canada. The company operated through cannabis cultivation, production management, and retail-related activities, primarily serving licensed cannabis operators, dispensaries, and wholesale cannabis markets. Its business model centered on developing and managing cultivation facilities and providing operational expertise for cannabis production in regulated jurisdictions.

The company was originally established as a cannabis cultivation management platform and expanded through acquisitions, licensing arrangements, and facility development projects during the broader growth cycle of the legal cannabis industry in the late 2010s. Public disclosures and market filings indicate that MJardin pursued a vertically integrated strategy involving cultivation, processing, and retail exposure through affiliated entities and partnerships. Publicly available information after 2022 became limited, and some operational and financial details are difficult to independently verify due to reduced public reporting activity. Data inconclusive based on available public sources regarding the company’s current operating scale and active business status.

Business Operations

MJardin generated revenue primarily through cannabis cultivation operations, facility management agreements, and cannabis product production. The company’s operating structure historically included cultivation assets and management services across regulated cannabis markets. Its operations were concentrated in U.S. states with legalized medical or adult-use cannabis frameworks, including activities associated with cultivation facilities and dispensary-related infrastructure. The company also pursued international exposure through Canadian public market participation and strategic investments linked to cannabis expansion opportunities.

The company controlled cultivation infrastructure, operational management systems, and cannabis production capabilities through affiliated operating entities and subsidiaries. Public filings referenced relationships with cultivation projects and operating partnerships in multiple jurisdictions, although several transactions and restructurings evolved over time. MJardin was also associated with cannabis retail and production brands through acquisitions and strategic investments. Information regarding currently active subsidiaries, joint ventures, or ongoing commercial partnerships is limited in recent public disclosures, and some prior operational relationships may no longer be active.

Strategic Position & Investments

MJardin’s strategic direction focused on scaling cannabis cultivation capacity and establishing a diversified footprint across multiple regulated cannabis markets. The company pursued growth through acquisitions, facility development projects, and investments in vertically integrated cannabis operations. Public disclosures referenced transactions involving cannabis cultivation and retail assets intended to strengthen market positioning in high-growth U.S. cannabis jurisdictions.

The company was involved in emerging segments of the legal cannabis sector, including indoor cultivation technologies, regulated retail operations, and production optimization services. Strategic initiatives included expanding licensed cultivation capacity and improving operational efficiencies in cannabis production environments. However, available public information suggests that the company faced broader industry challenges affecting many cannabis operators, including capital market volatility, regulatory complexity, and operational restructuring pressures. Data inconclusive based on available public sources regarding the company’s current acquisition pipeline or active investment strategy.

Geographic Footprint

MJardin Group maintained operational exposure primarily in North America, with activities concentrated in the United States and corporate connections to Canada through its public market presence. Historical disclosures identified operations and investments in several U.S. cannabis markets where medical or recreational cannabis had been legalized at the state level. The company’s headquarters and reporting structure were associated with Canadian corporate governance and public market frameworks while maintaining operational assets in the U.S.

Its market presence reflected the cross-border structure commonly used by cannabis companies seeking access to Canadian public capital markets while operating in U.S. state-regulated cannabis environments. Public information indicates that the company sought exposure to multiple regional cannabis markets rather than relying on a single jurisdiction. Current international operational influence and active geographic reach are difficult to independently verify based on recent publicly available disclosures.

Leadership & Governance

MJardin Group’s leadership historically consisted of executives with backgrounds in cannabis operations, finance, and capital markets. The company’s governance framework followed standard public-company structures applicable to Canadian-listed issuers, including executive leadership and board oversight tied to growth, operational scaling, and regulatory compliance within the cannabis sector.

Key executives identified in historical public filings and company disclosures included:

  • Pat Witcher – Chief Executive Officer
  • Rishi Gautam – Chief Financial Officer
  • Denis Taschuk – Executive Chairman
  • Joel Yaffe – Director and Strategic Advisor

Leadership strategy emphasized expansion in regulated cannabis markets, operational efficiency in cultivation management, and strategic acquisitions intended to build a vertically integrated cannabis platform. Some executive roles and governance structures may have changed over time, and recent independently verifiable information regarding current management composition is limited.

Data complied by narrative technology. May contain errors

Top Tech Stocks
See All »
B
NVDA NASDAQ $214.72
B
AAPL NASDAQ $309.35
B
AVGO NASDAQ $368.45
Top Consumer Staple Stocks
See All »
B
WMT NASDAQ $103.70
Top Financial Stocks
See All »
B
B
JPM NYSE $351.58
B
V NYSE $371.04
Top Health Care Stocks
See All »
B
LLY NYSE $1,255.40
B
JNJ NYSE $270.24
B
ABBV NYSE $264.96
Top Real Estate Stocks
See All »
B
PLD NYSE $141.80
B
EQIX NASDAQ $1,065.39